Quick Answer
CASI Pharmaceuticals, Inc. reported Shares Outstanding of 15.49 million shares for fiscal year 2024.
CASI Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 15.49M | +15.8% |
| 2023 | 13.38M | -0.6% |
| 2022 | 13.46M | -3.7% |
| 2021 | 13.98M | — |
- CASI Pharmaceuticals, Inc. showed an increase of +15.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2024 period, CASI Pharmaceuticals, Inc.’s shares outstanding has grown by 10.8% (from 13.98 million shares to 15.49 million shares).
- The most recent figure is from CASI Pharmaceuticals, Inc.’s fiscal year 2024 report (Form 20-F), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: